Onercept Terminated Phase 3 Trials for Psoriatic Arthritis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00090129Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis